Johnson & Johnson prepares to resume COVID vaccine trial in US

Credit: Unsplash / CC0 Public Domain

Johnson & Johnson said Friday it was preparing to continue the clinical trial of its experimental vaccine to fight COVID-19, which was suspended last week after a volunteer fell ill.

J&J said it “plans to resume recruiting” for the Phase 3 study, which began in late September and should eventually include 60,000 participants.

“After a thorough evaluation of a major medical event in a study participant, no clear cause was identified,” the group said in a statement.

“The company did not find any evidence that the vaccine candidate caused the event.”

Follow the latest news on the Coronavirus (COVID-19) outbreak

© 2020 AFP

Quote: Johnson & Johnson is preparing for the resumption of the US COVID vaccine study (2020, October 23), which will be released on October 23, 2020 from covid-vaccine-trial.html

This document is subject to copyright. Except for fair trade for the purpose of private study or research, no part may be reproduced without written permission. The content is provided for informational purposes only.